PLATELET ACTIVATING FACTOR AND EPIDERMAL CYTOTOXICITY
PLATELET ACTIVATING FACTOR AND EPIDERMAL CYTOTOXICITY
批准号:
6184728
负责人:
Jeffrey B. Travers
金额:
$25.21万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2003-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long-term objective of the proposed research is to elucidate the role of the glycerophosphocholine-derived mediator Platelet- activating Factor (PAF) in keratinocyte cytotoxicity. Recent studies have demonstrated that many clinically relevant cytotoxic agents including ultraviolet B (UVB) radiation damage human keratinocytes (HK) in part by inducing oxidative stress and cytokine production. Severe UVB damage to HK can also result in programmed cell death (apoptosis). Because PAF is synthesized in response to oxidative stress and many pro-inflammatory cytokines, and HK express PAF-receptors (PAF-R), involvement of the PAF system in UVB-mediated keratinocyte damage has been assessed using a model system created by retroviral-mediated transduction of the PAF-R into the PAF-R-negative epidermal cell line KB. Expression of the epidermal PAF-R resulted in an increased susceptibility to UVB-induced apoptosis. In addition, oxidative stress to epidermal cells resulted in the production of a PAF-R agonistic activity which mass spectrometric studies revealed was structurally not PAF. Based on the ability of antioxidants to inhibit this activity as well as the augmentation of UVB-induced apoptosis in PAF-R-expressing KB cells, we hypothesize oxidative damage to HK results in the production of oxidized lipids which can modulate apoptosis through PAF-R activation. Three specific aims will test this hypothesis by 1) Assessing the effects of PAF agonists/antagonists and overexpression of the wild-type or antisense PAF-R constructs on UVB-induced keratinocyte apoptosis in vitro; 2) Assessing the effects of PAF-R antagonists and overexpression of wild-type or antisense PAF-R constructs on UVB-induced apoptosis in SCID/HK xenografts in vivo; and 3) Structural characterization of the lipid species responsible for the UVB-induced non-PAF PAF-R agonistic activity in epidermal cells by mass spectrometry. The project will determine the significance of the PAF system in the oxidative stress response in HK, as well as to structurally define novel biologically active markers of lipid peroxidation, information which could result in potential therapeutic strategies involving PAF-R antagonists for diseases characterized by massive epidermal damage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation of Mesoscopic Imaging to Predict Cutaneous Carcinogenesis and its Therapeutic Response
-
批准号:10595503
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Jeffrey B. Travers
-
依托单位:
Validation of Mesoscopic Imaging to Predict Cutaneous Carcinogenesis and its Therapeutic Response
-
批准号:10295161
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Jeffrey B. Travers
-
依托单位:
Validation of Mesoscopic Imaging to Predict Cutaneous Carcinogenesis and its Therapeutic Response
-
批准号:10041690
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Jeffrey B. Travers
-
依托单位:
IGF-1 and the initiation of non-melanoma skin cancer
-
批准号:8967172
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Jeffrey B. Travers
-
依托单位:
IGF-1 and the initiation of non-melanoma skin cancer
-
批准号:8539867
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Jeffrey B. Travers
-
依托单位:
IGF-1 and the initiation of non-melanoma skin cancer
-
批准号:8892803
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Jeffrey B. Travers
-
依托单位:
IGF-1 and the initiation of non-melanoma skin cancer
-
批准号:9242476
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Jeffrey B. Travers
-
依托单位:
The Indiana Cutaneous Biological Research Training Program
-
批准号:8473519
-
项目类别:
-
资助金额:$13.14万
-
财政年份:2013
-
负责人:Jeffrey B. Travers
-
依托单位:
Oxidized lipids and UV immunosuppression
-
批准号:8391609
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Jeffrey B. Travers
-
依托单位:
Oxidized lipids and UV immunosuppression
-
批准号:8762399
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Jeffrey B. Travers
-
依托单位:
Oxidized lipids and UV immunosuppression
-
批准号:8597389
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Jeffrey B. Travers
-
依托单位:
Oxidized lipids and UV immunosuppression
-
批准号:7932683
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Jeffrey B. Travers
-
依托单位:
Oxidized Lipids and UV Immunosuppression
-
批准号:10293535
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Jeffrey B. Travers
-
依托单位:
Oxidized Lipids and UV Immunosuppression
-
批准号:10514568
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Jeffrey B. Travers
-
依托单位:
Oxidized lipids and UV immunosuppression
-
批准号:8196344
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Jeffrey B. Travers
-
依托单位:
Oxidized Lipids and UV Immunosuppression
-
批准号:10010381
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Jeffrey B. Travers
-
依托单位:
Bacterial Products as Potentiaters of AD
-
批准号:7150325
-
项目类别:
-
资助金额:$23.41万
-
财政年份:2006
-
负责人:Jeffrey B. Travers
-
依托单位:
PLATELET ACTIVATING FACTOR AND EPIDERMAL CYTOTOXICITY
-
批准号:6537618
-
项目类别:
-
资助金额:$30.98万
-
财政年份:1999
-
负责人:Jeffrey B. Travers
-
依托单位:
Platelet Activating Factor and Epidermal Cytoxicity
-
批准号:9883903
-
项目类别:
-
资助金额:$37.5万
-
财政年份:1999
-
负责人:Jeffrey B. Travers
-
依托单位:
Platelet Activating Factor and Epidermal Cytoxicity
-
批准号:10531858
-
项目类别:
-
资助金额:$37.5万
-
财政年份:1999
-
负责人:Jeffrey B. Travers
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: